Format

Send to

Choose Destination
Nat Rev Drug Discov. 2018 Dec;17(12):905-921. doi: 10.1038/nrd.2018.138. Epub 2018 Oct 12.

Therapeutic strategies targeting connexins.

Author information

1
Department of Anatomy & Cell Biology and Department of Physiology & Pharmacology, University of Western Ontario, London, Ontario, Canada.
2
Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Abstract

The connexin family of channel-forming proteins is present in every tissue type in the human anatomy. Connexins are best known for forming clustered intercellular channels, structurally known as gap junctions, where they serve to exchange members of the metabolome between adjacent cells. In their single-membrane hemichannel form, connexins can act as conduits for the passage of small molecules in autocrine and paracrine signalling. Here, we review the roles of connexins in health and disease, focusing on the potential of connexins as therapeutic targets in acquired and inherited diseases as well as wound repair, while highlighting the associated clinical challenges.

PMID:
30310236
PMCID:
PMC6461534
DOI:
10.1038/nrd.2018.138
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center